Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis.
Makaleler > Tam Makale · 2013
Yazarlar: Oğuz Reşat SİPAHİ, Selin BARDAK-OZCEM, Tuncer TURHAN, Bilgin ARDA, Mete RUKSEN, Hüsnü PULLUKÇU, Sohret AYDEMIR, Tayfun DALBASTI, Taşkın YURTSEVEN, Hilal SIPAHI, Mehmet ZİLELİ, Sercan ULUSOY
SURGICAL INFECTIONS, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2013, cilt 14, ss 357-362
DOI: 10.1089/sur.2012.091
Özet
Background: Vancomycin is the mainstay of treatment for methicillin-resistant Staphylococcus aureus (MRSA) meningitis. However, successful outcomes with linezolid have not been reported in a large series of patients. We conducted a single-center retrospective cohort study to compare vancomycin with linezolid in the treatment of MRSA meningitis.